Clinical Trial Update: Study Measuring Differences in Cognition Due to Sedative Effects of Risperidone and Quetiapine in Stable Bipolar I Outpatients [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing cognitive/sedative effects of risperidone vs. quetiapine in stable Bipolar I outpatients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Risperdal (risperidone)
• SEROQUEL (QUETIAPINE)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Bipolar Disorder | Phase 3 | Status: COMPLETED